Novo Nordisk challenges Pfizer with a $6.5 billion bid for Metsera, aiming to outbid Pfizer's earlier offer and reshape the obesity drug market.
Former deputy convicted of second-degree murder in Sonya Massey shooting, sparking mixed reactions and renewed scrutiny of law enforcement hiring practices.
Novo Nordisk challenges Pfizer with a $6.5 billion bid for Metsera, aiming to outbid Pfizer's earlier offer and reshape the obesity drug market.
Former deputy convicted of second-degree murder in Sonya Massey shooting, sparking mixed reactions and renewed scrutiny of law enforcement hiring practices.